What are you looking for?
Start main content
Professor WONG Wai Sun, Vincent

Professor WONG Wai Sun, Vincent

Assistant Dean (Development)

Mok Hing Yiu Professor of Medicine

Professor, Department of Medicine and Therapeutics

CUHK Employment
  • Assistant Dean (Development), Faculty of Medicine
  • Head, Division of Gastroenterology and Hepatology
  • Professor, Department of Medicine and Therapeutics
  • Mok Hing Yiu Professor of Medicine

  • Hepatology


Education & Qualifications

MBChB (CUHK), FHKCP, FHKAM (Medicine), MD (CUHK), FRCP (Edin), FRCP (Lond)



Research Interests
  • Non-alcoholic fatty liver disease
  • Viral hepatitis
  • Liver fibrosis

Additional Information


Professional Service

  • Associate Editor, Clinical Gastroenterology and Hepatology
  • Editorial Board Member, Journal of Hepatology, HEPATOLOGY, Alimentary Pharmacology & Therapeutics


Academic Engagement in CUHK

  • Mentor, MBChB Programme Global Physician-Leadership Stream (GPS)


Selected Publications

Researcher ID: 0000-0003-2215-9410


  1. Lee HW, Wong GL, Kwok R, Choi KC, Chan CK, Shu SS, Leung JK, Chim AM, Luk AO, Ma RC, Chan HL, Chan JC, Kong AP, Wong VW. Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study. Hepatology 2020;72(4):1230-124
  2. Wang Y, Wong GL, He FP, Sun J, Chan AW, Yang J, Shu SS, Liang X, Tse YK, Fan XT, Hou J, Chan HL, Wong VW. Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy. Gut 2020;69(6):1116-1126.
  3. Wong GL, Liang LY, Kwok R, Hui AJ, Tse YK, Chan HL, Wong VW. Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness. Hepatology 2019;70(3):971-981.
  4. Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019;68(11):2057-206
  5. Yip TC, Wong GL, Chan HL, Tse YK, Lam KL, Lui GC, Wong VW. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol 2019;70(3):361-370.
  6. Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, Chim AM, Chan CK, Leung JK, Chu WC, Woo J, Chan HL. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol 2018;69(6):1349-135
  7. Wong VW, Adams LA, de Lédinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat Rev Gastroenterol Hepatol 2018;15(8):461-478.
  8. Wong GL, Chan HL, Tse YK, Yip TC, Lam KL, Lui GC, Wong VW. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B. J Hepatol 2018;69(4):793-802.
  9. Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol 2017;67(4):862-873.
  10. Wong VW, Petta S, Hiriart JB, Cammà C, Wong GL, Marra F, Vergniol J, Chan AW, Tuttolomondo A, Merrouche W, Chan HL, Le Bail B, Arena U, Craxì A, de Lédinghen V. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol 2017;67(3):577-584.